News
TCG Lifesciences enters into a research collaboration with ENDO Pharmaceuticals
Date: January 11, 2010
Venue: Kolkata / New Delhi
TCG Lifesciences today announced a strategic collaboration with ENDO Pharmaceuticals (Nasdaq: ENDP) to discover novel small molecule drug candidates for the treatment of pain. Working closely with ENDO scientists the collaboration will focus on an integrated approach involving medicinal chemistry, biology and animal pharmacology capabilities of Chembiotek. ENDO will have full ownership of the compounds developed under the collaboration with exclusive worldwide rights, and will fund all subsequent drug development and commercialization activities. ENDO will provide research funding and pay success based discovery milestones payments to TCG Lifesciences.
Read More >>
Pfizer And TCG Lifesciences Announce A Collaboration To Develop Portfolio Of Preclinical Candidate Molecules
Date: January 5, 2010
Venue: Kolkata / New York
Pfizer Inc. (“PFE”) and TCG Lifesciences Limited (“TCGLS”) announce today that they have entered into a collaboration to develop a portfolio of preclinical candidate molecules in a series of discovery target programs.
TCGLS, which has a significant presence in Asia, will develop the compounds up to the nomination of preclinical candidates, encompassing medicinal chemistry, parallel medicinal chemistry, in-vitro ADME, in-vivo pharmacology, and preliminary safety and toxicology.
Pfizer will own the compounds, and TCGLS will receive research funding and will be eligible to receive research milestone payments as part of the partnership arrangement.
Read More >>
Frost & Sullivan 2009 India Excellence in Healthcare Award, CHEMBIOTEK recognized as Indian Drug Discovery Research Organization of the year. (Extracts from press release by Frost & Sullivan (India) Pvt. Ltd).
Date: September 9, 2008
Venue: Mumbai
Frost & Sullivan, for the first time, hosted '2009 India excellence in Healthcare Awards' at Mumbai. The Event attended by the creme de la creme of the healthcare industry spotlighted world-class companies that have performed par excellence and demonstrated best practices. Recognizing the best in class, the event was held to honor the country's premium players in the healthcare and research industry.
The F & S recognized 19 companies from the Medical Devices, Healthcare IT, Medical Imaging, Drug Discovery, Biotechnology and Clinical Diagnostics background. These companies have contributed and in the future would drive the growth of the industry through their market leadership, competitive strategies, and innovation.
Read More >>
Smell of Success
Date: November 19, 2008
Venue: Kolkata
One floor of Chembiotek, a TCG Lifesciences company in Kolkata, smells distinctly of fresh fruits. "Ketones," explains Purnendu Roy Chowdhury, who heads the analytical chemistry division. They have a brand new kiloscale synthesis lab in place. Another floor smells of freshly coated paint. Work's in progress.
That, in essence, is the mantra for the drug discovery research and development company — ongoing growth as you smell the results in the interim.
Swapan Bhattachharya, Managing Director of TCG Lifesciences, is not too bothered about the
dipping financial graphs across the world. "There would be an increase in outsourcing
irrespective of the world financial crisis.
Read More >>
Outfitting Asian Labs
Date: October 13, 2008
Venue: Kolkata
VISIT SCIENTIFIC LABS labs in India or China, and it becomes obvious that instrumentation makers are doing major business in those countries. From Bangalore to New Delhi, and from Beijing to Chongqing, more and more labs are conducting cutting-edge pharmaceutical research, diagnosing patients, testing water and air quality, or ascertaining whether food is safe.
The labs feature sophisticated instruments from well-known manufacturers, including Agilent Technologies, Bruker, Thermo Fisher Scientific, Varian, PerkinElmer, and Beckman Coulter. As these major instrument makers enjoy a surge in their Asian business, they are busily building their sales and technical support capabilities to meet customers' rising expectations. Asian instrument users who might once have been content with second-class treatment increasingly expect a level of attention and support from instrument companies comparable with what they offer customers in the U.S. or Europe.
Read More >>
Kilo Scale Synthesis Laboratory at Chembiotek, TCG Lifesciences, Kolkata
Date: August 6, 2008
Venue: Kolkata / Delhi, India
TCG Lifesciences Limited has commissioned its cGMP kilo scale synthesis laboratory in Kolkata at ‘Chembiotek,’ its discovery research services business unit. This represents a significant new step in establishing its fully integrated drug discovery and development research services offerings to the global pharmaceutical and biotechnology industries. With the aim to support its clients’ developmental needs by supplying material required for ‘First-in-human’ clinical studies, this facility has been designed with reactor capacity ranging up to 200L and reaction capabilities ranging from -80 to +200 degree Celsius. High end equipment, such as Differential Scanning Calorimeter and Reaction Calorimeter, have been installed with matching equipment like centrifuges, jet mills, vacuum tray dryers, sifters, etc. Following ‘safety through quality’ principle, the whole facility is integrated with a full scale Effluent Treatment Plant and due care has been taken to comply with stringent Health, Safety and Environmental (“HSE”) norms. A strong quality control team has been put in place to monitor achievement of the cGMP norms for the release of the material synthesized.
Read More >>
TCG Lifesciences Announces Strategic Partnership with Constella Group
Year: 2007
Venue: MUMBAI / KOLKATA
TCG Lifesciences, an India-based contract drug discovery and development company, today announced that it has entered into a partnership with Constella Group, a leading global provider of professional health services. As part of the non-exclusive relationship, TCG Lifesciences and Constella will jointly promote their contract services and identify and promote business opportunities across the two organizations.
Read More >>
Archives
Press releases 2007
TCG Life offers R&D
Best practices in project management
TCG inks Strategic deal with Forest Laboratories Holdings
TCG Lifesciences Announces Strategic Partnership with Constella Group
TCG Lifesciences enters into a research collaboration with Forest Laboratories
